Global Prefilled Syringes Market: By Material Type (Plastic Prefilled Syringes and Glass Prefilled Syringes), By Prefilled Syringes Type (Conventional Prefilled Syringes and Safety Prefilled Syringes), By Design (Single Chamber PFS, Dual-chamber PFS, and Customized PFS), End Users (Pharmaceutical Companies, Biopharmaceutical Companies, Drug Discovery & Research Organizations, and Others), and Geography - Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

September 2017 | 202 pages | ID: G5DA35C81BDEN
Precision Business Insights (PBI)

Abstracts

Global Prefilled Syringes Market Report Description:

Prefilled syringes market report gives comprehensive outlook on prefilled syringes across the globe with special emphasis on key regions such as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa (MEA). The report on prefilled syringes market gives historical, current, and future market sizes (US$ Mn) on the basis of material type, prefilled syringes type, design, end user, and geographic regions. This report studies prefilled syringes market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, prefilled syringes market report includes new product introduction, regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed prefilled syringes market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the prefilled syringes market report include suppliers, manufacturers, marketers, policy makers engaged in manufacturing and supply of prefilled syringes.

Prefilled Syringes Market:

The prefilled syringes market estimated to be valued US$ 4,385 Mn in 2016 and poised to grow at CAGR 8.8%. Market for prefilled syringes projected to reach US$ 7,276 Mn by 2023.

Rise in biologic drug approvals and pipeline

Increasing adoption prefilled syringes format for parenteral drug administration, rising biologic product approvals, increased product availability in PFS format for home based healthcare, and safety associated with prefilled syringes driving market revenue growth of prefilled syringes market over the forecast period. Moreover, inherited benefits such as dose accuracy, convenience in usage, sterility and advantages over conventional drug delivery are the factors driving the prefilled syringes market revenue growth.

Availability of alternate drug administration methods

Pharmaceutical and biopharmaceutical companies yet to exploit the full potential of prefilled syringes formats for drug administration and this non adoption of PFS formats can be attributes to the availability of other alternative drug administration methods. In addition, lower penetration of PFS in developing economies hindering market revenues growth over forecast period. Currently majority of PFS are designed to compatible with biologic drugs than non-biologic drugs.

Europe accounts for larger market revenue share in global prefilled syringes market

Europe expected to lead the global prefilled syringes market in terms of revenue in over forecast period. Regions such as Asia Pacific and North America presented better growth opportunities for the market players owing to rise in prevalence of chronic diseases and availability of large untapped market.

COMPETITION ASSESSMENT

Key players profiles in the global prefilled syringes market include:

• Becton, Dickinson and Company (U.S.)
• Catalent, Inc. (U.S.)
• Gerresheimer (Germany)
• Haselmeier (Switzerland)
• MedPro Inc. (U.S.)
• Nipro Corporation (Japan)
• Ompi (Italy)
• Owen Mumford (UK)
• SCHOTT AG (Germany)
• Terumo Medical Corporation (Japan)
• Unilife Corporation (U.S.)
• Vetter Pharma International GmbH (Germany)
• Weigao Group (China)
• West Pharmaceutical Services, Inc. (U.S.)
• Ypsomed Holding AG (Switzerland)

Market players are focusing on launching innovative and customized prefilled syringes to maintain market position in global prefilled syringes market. Moreover, players are entering into strategic agreement with pharmaceutical and biopharmaceutical companies to improve revenue prospects.

KEY FINDINGS OF THE REPORT:

• Prefilled Syringes market expanding at 8.8% CAGR over 2017 to 2023 to reach market value of US$ 7,276 Mn by 2023 owing increased adoption in home-based healthcare market
• Based on material type glass based prefilled syringes accounted for larger market share in 2016 owing to compatibility with several drug molecules
• Biopharmaceutical companies are major buyers for global prefilled syringes market owing to availability of wider biologic drugs in PFS format
• Players focusing on introducing novel prefilled syringes to garner market global market opportunities

KEY FEATURES OF THE REPORT:

• The report provides granular level information about the market size, regional market share, historic market (2012-2016) and forecast (2017-2023)
• The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
• The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
• The report tracks recent innovations, key developments and startup’s details that are actively working in the market
• The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
• The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

DETAILED SEGMENTATION

By Material Type

• Plastic Prefilled Syringes
• Glass Prefilled Syringes

By Prefilled Syringes Type

• Conventional Prefilled Syringes
• Safety Prefilled Syringes

By Design

• Single Chamber PFS
• Dual-chamber PFS
• Customized PFS

End Users

• Pharmaceutical Companies
• Biopharmaceutical Companies
• Drug Discovery & Research Organizations
• Others

Geography

• North America
• U.S
• Canada
• Europe
• Germany
• France
• U.K
• Italy
• Spain
• Russia
• Poland
• Rest of Europe
• Asia-Pacific
• Japan
• China
• India
• Australia & New Zealand
• ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
• South Korea
• Rest of Asia-Pacific
• Latin America
• Brazil
• Mexico
• Argentina
• Venezuela
• Rest of Latin America
• Middle East and Africa (MEA)
• Gulf Cooperation Council (GCC) Countries
• Israel
• South Africa

Rest of MEA

Contents

1. RESEARCH METHODOLOGY

1.1. Secondary and Primary research
  1.1.1. Secondary Sources
  1.1.2. Primary Sources
1.2. Market Revenue Estimation Methodology
1.3. Key Assumptions
1.4. Acronyms

2. SCOPE OF STUDY

2.1. Market Definition
2.2. Objective of the Research
2.3. Regions covered in the study

3. EXECUTIVE SUMMARY

4. GLOBAL PREFILLED SYRINGES (PFS) MARKET DYNAMICS

4.1. Drivers
  4.1.1. Economic Drivers
  4.1.2. Demand Side Drivers
  4.1.3. Supply Side Drivers
4.2. Restraints
4.3. Opportunities/Unmet Needs of the Market
4.4. Trends

5. UNIQUE FEATURES OF THE REPORT

5.1. Competition analysis
5.2. Regulatory landscape
5.3. PESTLE analysis
5.4. Porter’s analysis

6. GLOBAL PREFILLED SYRINGES (PFS) MARKET ANALYSIS, BY MATERIAL TYPE, 2012 - 2016 AND FORECAST, 2017 - 2023

6.1. Plastic Prefilled Syringes
  6.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
  6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
6.2. Glass Prefilled Syringes
  6.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
  6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%)

7. GLOBAL PREFILLED SYRINGES (PFS) MARKET ANALYSIS, BY PREFILLED SYRINGES TYPE, 2012 - 2016 AND FORECAST, 2017 - 2023

7.1. Conventional Prefilled Syringes
  7.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
  7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
7.2. Safety Prefilled Syringes
  7.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
  7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%)

8. GLOBAL PREFILLED SYRINGES (PFS) MARKET ANALYSIS, BY DESIGN, 2012 - 2016 AND FORECAST, 2017 - 2023

8.1. Single Chamber PFS
  8.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
  8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
8.2. Dual-chamber PFS
  8.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
  8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
8.3. Customized PFS
  8.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
  8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%)

9. GLOBAL PREFILLED SYRINGES (PFS) MARKET FORECAST, BY END USER ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

9.1. Pharmaceutical Companies
  9.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
  9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
9.2. Biopharmaceutical Companies
  9.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
  9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
9.3. Drug Discovery & Research Organizations
  9.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
  9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
9.4. Others
  9.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
  9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)

10. PREFILLED SYRINGES (PFS) MARKET ANALYSIS, BY REGION, 2012 - 2016 AND FORECAST, 2017 - 2023

10.1. North America Prefilled Syringes (PFS) Market Analysis, 2012 - 2016 and Forecast, 2017 - 2023
  10.1.1. Material Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
    10.1.1.1. Plastic Prefilled Syringes
    10.1.1.2. Glass Prefilled Syringes
  10.1.2. Prefilled Syringes Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
    10.1.2.1. Conventional Prefilled Syringes
    10.1.2.2. Safety Prefilled Syringes
  10.1.3. Design Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
    10.1.3.1. Single Chamber PFS
    10.1.3.2. Dual-chamber PFS
    10.1.3.3. Customized PFS
  10.1.4. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
    10.1.4.1. Pharmaceutical Companies
    10.1.4.2. Biopharmaceutical Companies
    10.1.4.3. Drug Discovery & Research Organizations
    10.1.4.4. Others
  10.1.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
    10.1.5.1. U.S.
    10.1.5.2. Canada
10.2. Europe Prefilled Syringes (PFS) Market Analysis, 2012 - 2016 and Forecast, 2017 - 2023
  10.2.1. Material Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
    10.2.1.1. Plastic Prefilled Syringes
    10.2.1.2. Glass Prefilled Syringes
  10.2.2. Prefilled Syringes Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
    10.2.2.1. Conventional Prefilled Syringes
    10.2.2.2. Safety Prefilled Syringes
  10.2.3. Design Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
    10.2.3.1. Single Chamber PFS
    10.2.3.2. Dual-chamber PFS
    10.2.3.3. Customized PFS
  10.2.4. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
    10.2.4.1. Pharmaceutical Companies
    10.2.4.2. Biopharmaceutical Companies
    10.2.4.3. Drug Discovery & Research Organizations
    10.2.4.4. Others
  10.2.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
    10.2.5.1. U.K
    10.2.5.2. Germany
    10.2.5.3. France
    10.2.5.4. Italy
    10.2.5.5. Spain
    10.2.5.6. Russia
    10.2.5.7. Poland 10.2.5.8. Rest of Europe
10.3. Asia-Pacific Prefilled Syringes (PFS) Market Analysis, 2012 - 2016 and Forecast, 2017 - 2023
  10.3.1. Material Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
    10.3.1.1. Plastic Prefilled Syringes
    10.3.1.2. Glass Prefilled Syringes
  10.3.2. Prefilled Syringes Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
    10.3.2.1. Conventional Prefilled Syringes
    10.3.2.2. Safety Prefilled Syringes
  10.3.3. Design Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
    10.3.3.1. Single Chamber PFS
    10.3.3.2. Dual-chamber PFS
    10.3.3.3. Customized PFS
  10.3.4. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
    10.3.4.1. Pharmaceutical Companies
    10.3.4.2. Biopharmaceutical Companies
    10.3.4.3. Drug Discovery & Research Organizations
    10.3.4.4. Others
  10.3.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
    10.3.5.1. Japan
    10.3.5.2. China
    10.3.5.3. India
    10.3.5.4. ASEAN
    10.3.5.5. Australia & New Zealand 10.3.5.6. Rest of Asia-Pacific
10.4. Latin America Prefilled Syringes (PFS) Market Analysis, 2012 - 2016 and Forecast, 2017 - 2023
  10.4.1. Material Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
    10.4.1.1. Plastic Prefilled Syringes
    10.4.1.2. Glass Prefilled Syringes
  10.4.2. Prefilled Syringes Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
    10.4.2.1. Conventional Prefilled Syringes
    10.4.2.2. Safety Prefilled Syringes
  10.4.3. Design Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
    10.4.3.1. Single Chamber PFS
    10.4.3.2. Dual-chamber PFS
    10.4.3.3. Customized PFS
  10.4.4. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
    10.4.4.1. Pharmaceutical Companies
    10.4.4.2. Biopharmaceutical Companies
    10.4.4.3. Drug Discovery & Research Organizations
    10.4.4.4. Others
  10.4.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
    10.4.5.1. Brazil
    10.4.5.2. Mexico
    10.4.5.3. Argentina
    10.4.5.4. Venezuela
    10.4.5.5. Rest of Latin America
10.5. Middle East & Africa (MEA) Prefilled Syringes (PFS) Market Analysis, 2012 - 2016 and Forecast, 2017 - 2023
  10.5.1. Material Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
    10.5.1.1. Plastic Prefilled Syringes
    10.5.1.2. Glass Prefilled Syringes
  10.5.2. Prefilled Syringes Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
    10.5.2.1. Conventional Prefilled Syringes
    10.5.2.2. Safety Prefilled Syringes
  10.5.3. Design Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
    10.5.3.1. Single Chamber PFS
    10.5.3.2. Dual-chamber PFS
    10.5.3.3. Customized PFS
  10.5.4. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
    10.5.4.1. Pharmaceutical Companies
    10.5.4.2. Biopharmaceutical Companies
    10.5.4.3. Drug Discovery & Research Organizations
    10.5.4.4. Others
  10.5.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
    10.5.5.1. Gulf Cooperation Council (GCC) Countries
    10.5.5.2. Israel
    10.5.5.3. South Africa
    10.5.5.4. Rest of MEA

11. COMPETITION LANDSCAPE

11.1. Strategic Dashboard of Top Market Players
11.2. Company Profiles (Introduction, Financial Analysis, Component & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
  11.2.1. Becton, Dickinson and Company (U.S.)
  11.2.2. Catalent, Inc. (U.S.)
  11.2.3. Gerresheimer (Germany)
  11.2.4. Haselmeier (Switzerland)
  11.2.5. MedPro Inc. (U.S.)
  11.2.6. Nipro Corporation (Japan)
  11.2.7. Ompi (Italy)
  11.2.8. Owen Mumford (UK)
  11.2.9. SCHOTT AG (Germany)
  11.2.10. Terumo Medical Corporation (Japan)
  11.2.11. Unilife Corporation (U.S.)
  11.2.12. Vetter Pharma International GmbH (Germany)
  11.2.13. Weigao Group (China)
  11.2.14. West Pharmaceutical Services, Inc. (U.S.)
  11.2.15. Ypsomed Holding AG (Switzerland)